ResMed Forecast, price target & analysts
ResMed Target price 2026 - Analyst rating & recommendation
ResMed Classifications & Recommendation
ResMed Price Target
| Target Price | $239.70 |
| Price | $246.20 |
| Deviation | |
| Number of Estimates | 19 |
| 19 Analysts have issued a price target ResMed 2027 . The average ResMed target price is $239.70. This is lower than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 27 analysts: 13 Analysts recommend ResMed to buy, 12 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the ResMed stock has an average upside potential 2027 of . Most analysts recommend the ResMed stock at Purchase. |
Sales and Margin forecast 2027, 2028 & 2029
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
29 Analysts have issued a sales forecast ResMed 2027 . The average ResMed sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
23 Analysts have issued an ResMed EBITDA forecast 2027. The average ResMed EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
23 ResMed Analysts have issued a net profit forecast 2027. The average ResMed net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
Current ResMed Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
